STAAR Surgical Company (STAA)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 78.36% | 77.92% | 77.97% | 78.61% | 78.55% | 78.25% | 77.75% | 77.70% | 77.51% | 77.23% | 76.39% | 74.15% | 72.41% | 72.20% | 72.19% | 73.65% | 74.54% | 74.48% | 74.65% | 74.36% |
| Operating profit margin | 8.71% | 6.01% | 8.52% | 11.70% | 15.40% | 17.98% | 16.95% | 15.64% | 14.47% | 13.81% | 13.13% | 8.59% | 4.14% | 3.22% | 2.35% | 5.99% | 7.89% | 7.51% | 6.62% | 5.69% |
| Pretax margin | 10.45% | 8.36% | 10.38% | 13.15% | 16.02% | 16.66% | 15.80% | 15.06% | 13.58% | 13.39% | 13.16% | 8.82% | 5.06% | 4.13% | 2.84% | 6.47% | 8.67% | 7.98% | 7.41% | 5.88% |
| Net profit margin | 6.62% | 6.27% | 8.14% | 10.81% | 13.63% | 13.54% | 12.83% | 11.98% | 10.63% | 10.53% | 10.08% | 6.17% | 3.62% | 5.73% | 5.03% | 8.21% | 9.35% | 6.15% | 5.80% | 4.44% |
STAAR Surgical Company's profitability ratios have shown varying trends over the past five years. The gross profit margin has generally been consistently high, averaging around 77-78% in recent quarters, indicating that the company efficiently controls its production costs.
On the other hand, the operating profit margin has displayed more fluctuations, with a significant decrease in the most recent quarter to 6.01% from previous levels exceeding 15%. This suggests that the company's operating expenses have increased relative to sales, impacting profitability.
Similarly, the pretax margin has also shown fluctuations over the period, reaching 10.45% in the latest quarter. This ratio reflects the company's ability to generate profits before accounting for taxes and indicates a trend of profitability that has been sensitive to changes in expenses and revenues.
The net profit margin, representing the final profitability after all expenses, has also varied, but generally tends to be lower than the operating profit margins. The company has shown a net profit margin of 6.62% in the most recent quarter, reflecting its ability to translate revenues into net income, although it has shown declining trends over the past quarters.
Overall, STAAR Surgical Company has demonstrated solid gross profit margins but has faced challenges in controlling operating expenses and maximizing net profitability in recent quarters, as reflected in the fluctuating operating, pretax, and net profit margins.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 5.75% | 3.96% | 5.92% | 8.23% | 10.46% | 12.72% | 11.80% | 10.82% | 9.64% | 9.25% | 9.20% | 5.78% | 2.63% | 2.14% | 1.60% | 4.43% | 5.71% | 5.55% | 4.81% | 4.15% |
| Return on assets (ROA) | 4.37% | 4.12% | 5.65% | 7.61% | 9.25% | 9.58% | 8.93% | 8.29% | 7.09% | 7.06% | 7.06% | 4.15% | 2.30% | 3.82% | 3.42% | 6.07% | 6.77% | 4.55% | 4.21% | 3.25% |
| Return on total capital | 7.28% | 4.93% | 7.29% | 10.18% | 13.03% | 15.54% | 14.67% | 13.75% | 12.75% | 12.06% | 11.54% | 7.18% | 3.43% | 2.70% | 2.00% | 5.55% | 7.41% | 7.16% | 6.20% | 5.36% |
| Return on equity (ROE) | 5.53% | 5.14% | 6.96% | 9.40% | 11.53% | 11.71% | 11.11% | 10.54% | 9.37% | 9.20% | 8.86% | 5.15% | 3.00% | 4.81% | 4.27% | 7.61% | 8.79% | 5.87% | 5.43% | 4.19% |
The profitability ratios of STAAR Surgical Company have shown some fluctuations over the past few quarters.
- Operating return on assets (Operating ROA) has been decreasing steadily from 12.72% in September 2022 to 5.75% in December 2023, indicating a decline in the company's ability to generate profit from its assets through core operations.
- Return on assets (ROA) has also shown a decreasing trend from 9.58% in September 2022 to 4.37% in December 2023, reflecting a decline in the overall profitability of the company relative to its total assets.
- Return on total capital has followed a similar downward trend, decreasing from 15.54% in September 2022 to 7.28% in December 2023, indicating a reduction in the company's profitability in relation to its total invested capital.
- Return on equity (ROE) has fluctuated over the quarters but generally has been decreasing, from 11.71% in September 2022 to 5.53% in December 2023, showing a decrease in profitability in relation to shareholder equity.
Overall, the decreasing trend in profitability ratios suggests that STAAR Surgical Company may be experiencing challenges in maintaining or improving its profitability levels. This could be due to various factors such as changes in operating efficiency, increased costs, or changing market conditions. Further analysis and investigation into the company's financial performance and operations may be required to identify the specific reasons behind these trends and to develop strategies for improvement.